Back to FMR LLC FMR LLC

MLTXMLTX
7 quarters

Position history for FMR LLCFMR LLC's holdings in MoonLake Immunotherapeutics Class A

FMR LLC holds 143,559 shares of MLTX (MoonLake Immunotherapeutics Class A), worth $2.8M as of 2026-Q2. MLTX represents 0.0% of FMR LLC's portfolio.

Current Value

$2.8M

Current Shares

143,559

Total Value Change

-$340.6M

Total Shares Change

-6.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
143,559
0.0%
$2.8M0.0%$19.47
0
2026-Q1
Decreased
143,559
-8.1%
$2.7M0.0%$17.69
0
2025-Q4
Decreased
156,276
-78.5%
$2.1M0.0%$13.21
0
2025-Q3
Decreased
726,932
-87.3%
$5.2M0.0%$6.24
0
2025-Q2
Decreased
5.7M
-9.4%
$270.5M0.0%$47.52
0
2025-Q1
Decreased
6.3M
-0.2%
$247.2M0.0%$39.86
0
2024-Q4
New
6.3M
-
$343.4M0.0%$53.02
43

Other major holders of MLTX: Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used